OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
BMJ Publishing Group
2017
|
| _version_ | 1826279314481479680 |
|---|---|
| author | Wechsler, M Akuthota, P Jayne, D Khoury, P Klion, A Langford, C Merkel, P Moosig, F Specks, U Cid, M Luqmani, R Brown, J Mallett, S Philipson, R Yancey, S Steinfeld, J Weller, P Gleich, G |
| author_facet | Wechsler, M Akuthota, P Jayne, D Khoury, P Klion, A Langford, C Merkel, P Moosig, F Specks, U Cid, M Luqmani, R Brown, J Mallett, S Philipson, R Yancey, S Steinfeld, J Weller, P Gleich, G |
| author_sort | Wechsler, M |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T23:56:52Z |
| format | Conference item |
| id | oxford-uuid:748415e4-e566-49d6-a762-b41bdc7233bd |
| institution | University of Oxford |
| last_indexed | 2024-03-06T23:56:52Z |
| publishDate | 2017 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:748415e4-e566-49d6-a762-b41bdc7233bd2022-03-26T20:03:32ZOP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trialConference itemhttp://purl.org/coar/resource_type/c_5794uuid:748415e4-e566-49d6-a762-b41bdc7233bdSymplectic Elements at OxfordBMJ Publishing Group2017Wechsler, MAkuthota, PJayne, DKhoury, PKlion, ALangford, CMerkel, PMoosig, FSpecks, UCid, MLuqmani, RBrown, JMallett, SPhilipson, RYancey, SSteinfeld, JWeller, PGleich, G |
| spellingShingle | Wechsler, M Akuthota, P Jayne, D Khoury, P Klion, A Langford, C Merkel, P Moosig, F Specks, U Cid, M Luqmani, R Brown, J Mallett, S Philipson, R Yancey, S Steinfeld, J Weller, P Gleich, G OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial |
| title | OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial |
| title_full | OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial |
| title_fullStr | OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial |
| title_full_unstemmed | OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial |
| title_short | OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial |
| title_sort | op0130 mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis a phase iii randomised placebo controlled trial |
| work_keys_str_mv | AT wechslerm op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT akuthotap op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT jayned op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT khouryp op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT kliona op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT langfordc op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT merkelp op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT moosigf op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT specksu op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT cidm op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT luqmanir op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT brownj op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT malletts op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT philipsonr op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT yanceys op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT steinfeldj op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT wellerp op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial AT gleichg op0130mepolizumabforthetreatmentofpatientswitheosinophilicgranulomatosiswithpolyangiitisaphaseiiirandomisedplacebocontrolledtrial |